Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. - Spriano F; Tarantelli C; Cascione L; Gaudio E; Golino G; Scalise L; Cacciapuoti MT; Zucca E; Stathis A; Van Berkel PH; Inghirami G; Zammarchi F; et al. (British journal of haematology, 2024)